294 related articles for article (PubMed ID: 20172855)
41. The receptor for parathyroid hormone and parathyroid hormone-related peptide is hydrolyzed and its signaling properties are altered by directly binding the calpain small subunit.
Shimada M; Mahon MJ; Greer PA; Segre GV
Endocrinology; 2005 May; 146(5):2336-44. PubMed ID: 15691895
[TBL] [Abstract][Full Text] [Related]
42. TGF-beta type II receptor phosphorylates PTH receptor to integrate bone remodelling signalling.
Qiu T; Wu X; Zhang F; Clemens TL; Wan M; Cao X
Nat Cell Biol; 2010 Mar; 12(3):224-34. PubMed ID: 20139972
[TBL] [Abstract][Full Text] [Related]
43. Cooperative interaction of arginine-19 and the N-terminal signaling domain in the affinity and potency of parathyroid hormone.
Tsomaia N; Shimizu M; Shimizu N; Gardella TJ; Mierke DF
Biochemistry; 2004 Mar; 43(12):3459-70. PubMed ID: 15035617
[TBL] [Abstract][Full Text] [Related]
44. Photoaffinity cross-linking identifies differences in the interactions of an agonist and an antagonist with the parathyroid hormone/parathyroid hormone-related protein receptor.
Behar V; Bisello A; Bitan G; Rosenblatt M; Chorev M
J Biol Chem; 2000 Jan; 275(1):9-17. PubMed ID: 10617579
[TBL] [Abstract][Full Text] [Related]
45. Molecular Mechanisms of PTH/PTHrP Class B GPCR Signaling and Pharmacological Implications.
Vilardaga JP; Clark LJ; White AD; Sutkeviciute I; Lee JY; Bahar I
Endocr Rev; 2023 May; 44(3):474-491. PubMed ID: 36503956
[TBL] [Abstract][Full Text] [Related]
46. Molecular properties of the PTH/PTHrP receptor.
Gardella TJ; Jüppner H
Trends Endocrinol Metab; 2001 Jul; 12(5):210-7. PubMed ID: 11397646
[TBL] [Abstract][Full Text] [Related]
47. Molecular basis of parathyroid hormone receptor signaling and trafficking: a family B GPCR paradigm.
Vilardaga JP; Romero G; Friedman PA; Gardella TJ
Cell Mol Life Sci; 2011 Jan; 68(1):1-13. PubMed ID: 20703892
[TBL] [Abstract][Full Text] [Related]
48. Parathyroid hormone (PTH) and PTH-related peptide domains contributing to activation of different PTH receptor-mediated signaling pathways.
Cupp ME; Nayak SK; Adem AS; Thomsen WJ
J Pharmacol Exp Ther; 2013 Jun; 345(3):404-18. PubMed ID: 23516330
[TBL] [Abstract][Full Text] [Related]
49. Novel parathyroid hormone (PTH) antagonists that bind to the juxtamembrane portion of the PTH/PTH-related protein receptor.
Shimizu N; Dean T; Tsang JC; Khatri A; Potts JT; Gardella TJ
J Biol Chem; 2005 Jan; 280(3):1797-807. PubMed ID: 15550385
[TBL] [Abstract][Full Text] [Related]
50. A docking site for G protein βγ subunits on the parathyroid hormone 1 receptor supports signaling through multiple pathways.
Mahon MJ; Bonacci TM; Divieti P; Smrcka AV
Mol Endocrinol; 2006 Jan; 20(1):136-46. PubMed ID: 16099817
[TBL] [Abstract][Full Text] [Related]
51. Modulation of PTH1R signaling by an extracellular binding antibody.
Sarkar K; Joedicke L; Westwood M; Burnley R; Wright M; McMillan D; Byrne B
Vitam Horm; 2022; 120():109-132. PubMed ID: 35953107
[TBL] [Abstract][Full Text] [Related]
52. Parathyroid hormone and parathyroid hormone-related peptide, and their receptors.
Gensure RC; Gardella TJ; Jüppner H
Biochem Biophys Res Commun; 2005 Mar; 328(3):666-78. PubMed ID: 15694400
[TBL] [Abstract][Full Text] [Related]
53. NHERF1 regulates parathyroid hormone receptor desensitization: interference with beta-arrestin binding.
Wang B; Yang Y; Abou-Samra AB; Friedman PA
Mol Pharmacol; 2009 May; 75(5):1189-97. PubMed ID: 19188335
[TBL] [Abstract][Full Text] [Related]
54. Juxtamembrane region of the amino terminus of the corticotropin releasing factor receptor type 1 is important for ligand interaction.
Assil IQ; Qi LJ; Arai M; Shomali M; Abou-Samra AB
Biochemistry; 2001 Feb; 40(5):1187-95. PubMed ID: 11170443
[TBL] [Abstract][Full Text] [Related]
55. Identification of a contact site for residue 19 of parathyroid hormone (PTH) and PTH-related protein analogs in transmembrane domain two of the type 1 PTH receptor.
Gensure RC; Shimizu N; Tsang J; Gardella TJ
Mol Endocrinol; 2003 Dec; 17(12):2647-58. PubMed ID: 12947048
[TBL] [Abstract][Full Text] [Related]
56. Physiological and Pharmacological Roles of PTH and PTHrP in Bone Using Their Shared Receptor, PTH1R.
Martin TJ; Sims NA; Seeman E
Endocr Rev; 2021 Jul; 42(4):383-406. PubMed ID: 33564837
[TBL] [Abstract][Full Text] [Related]
57. Mechanisms of ligand binding to the parathyroid hormone (PTH)/PTH-related protein receptor: selectivity of a modified PTH(1-15) radioligand for GalphaS-coupled receptor conformations.
Dean T; Linglart A; Mahon MJ; Bastepe M; Jüppner H; Potts JT; Gardella TJ
Mol Endocrinol; 2006 Apr; 20(4):931-43. PubMed ID: 16339275
[TBL] [Abstract][Full Text] [Related]
58. Extracellular nucleotides enhance agonist potency at the parathyroid hormone 1 receptor.
Kim BH; Pereverzev A; Zhu S; Tong AOM; Dixon SJ; Chidiac P
Cell Signal; 2018 Jun; 46():103-112. PubMed ID: 29501726
[TBL] [Abstract][Full Text] [Related]
59. Role of asparagine-linked oligosaccharides in the function of the rat PTH/PTHrP receptor.
Zhou AT; Assil I; Abou-Samra AB
Biochemistry; 2000 May; 39(21):6514-20. PubMed ID: 10828967
[TBL] [Abstract][Full Text] [Related]
60. Abaloparatide, the second generation osteoanabolic drug: Molecular mechanisms underlying its advantages over the first-in-class teriparatide.
Bhattacharyya S; Pal S; Chattopadhyay N
Biochem Pharmacol; 2019 Aug; 166():185-191. PubMed ID: 31136739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
